Hasan Abbas Zaheer: Honoured to Have Co-Authored One of the Four Reviews in The Lancet Thalassemia Series
Hasan Abbas Zaheer, Member of National Technical Advisory Committee, M/o National Health Services, Advisor at World Health Organization, shared a post on LinkedIn:
“The Lancet Thalassemia Series launches next week in The Lancet Haematology. Bringing together 48 international experts from 28 countries, the Series takes a comprehensive look at thalassemia; from the evolving epidemiology and prevention landscape to the global treatment paradigm and the future of care.
I am honoured to be a co-author of one of the four reviews, ‘Future-proofing thalassemia care: harnessing scalable therapies, artificial intelligence, and global collaboration.’
The review explores how scalable therapeutic approaches, emerging technologies, artificial intelligence, and stronger international collaboration could help reshape thalassemia care for the decades ahead, particularly in settings where access to specialist treatment remains limited.
I hope this collective work will contribute to a broader global effort to ensure that high-quality, evidence-based thalassemia care is accessible to every patient, regardless of where they live.”
Stay updated with Hemostasis Today.
-
Oct 5, 2026, 22:34Kamyar Shameli: Understanding the Coagulation Cascade – How Anticoagulants Prevent Blood Clots
-
Oct 5, 2026, 22:31Risika Samanta: Pediatric ITP in a 12-year-old – An Atypical Presentation without a Viral Prodrome
-
Oct 5, 2026, 22:25Allie Boutin: Raising Awareness and Supporting the Community During ITP Awareness Month
-
Oct 5, 2026, 15:31Irma Bagdoniene: Multidisciplinary Management of High-Risk Familial Hypercholesterolaemia and CAD
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies